NO962714L - Fremgangsmåte for selektiv metionin-utsulting av maligne celler i pattedyr - Google Patents
Fremgangsmåte for selektiv metionin-utsulting av maligne celler i pattedyrInfo
- Publication number
- NO962714L NO962714L NO962714A NO962714A NO962714L NO 962714 L NO962714 L NO 962714L NO 962714 A NO962714 A NO 962714A NO 962714 A NO962714 A NO 962714A NO 962714 L NO962714 L NO 962714L
- Authority
- NO
- Norway
- Prior art keywords
- malignant cells
- mammal
- mtase
- methionine
- cells
- Prior art date
Links
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 title abstract 3
- 230000003211 malignant effect Effects 0.000 title abstract 3
- 229930182817 methionine Natural products 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 235000003642 hunger Nutrition 0.000 title 1
- 230000037351 starvation Effects 0.000 title 1
- 108010034457 5'-methylthioadenosine phosphorylase Proteins 0.000 abstract 5
- 102100034187 S-methyl-5'-thioadenosine phosphorylase Human genes 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- WUUGFSXJNOTRMR-IOSLPCCCSA-N 5'-S-methyl-5'-thioadenosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CSC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 WUUGFSXJNOTRMR-IOSLPCCCSA-N 0.000 abstract 1
- 108010043135 L-methionine gamma-lyase Proteins 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/176,413 US5571510A (en) | 1993-12-29 | 1993-12-29 | Method for selective methionine starvation of malignant cells in mammals |
| PCT/US1994/014919 WO1995017908A1 (en) | 1993-12-29 | 1994-12-22 | Method for selective methionine starvation of malignant cells in mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO962714D0 NO962714D0 (no) | 1996-06-27 |
| NO962714L true NO962714L (no) | 1996-08-26 |
Family
ID=22644262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO962714A NO962714L (no) | 1993-12-29 | 1996-06-27 | Fremgangsmåte for selektiv metionin-utsulting av maligne celler i pattedyr |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5571510A (de) |
| EP (1) | EP0805690B1 (de) |
| JP (1) | JPH09507754A (de) |
| CN (1) | CN1143325A (de) |
| AT (1) | ATE221785T1 (de) |
| AU (1) | AU694161B2 (de) |
| CA (1) | CA2180262A1 (de) |
| CZ (1) | CZ291281B6 (de) |
| DE (1) | DE69431167T2 (de) |
| HU (1) | HU221341B1 (de) |
| NO (1) | NO962714L (de) |
| NZ (1) | NZ278271A (de) |
| PL (1) | PL182298B1 (de) |
| RO (1) | RO117542B1 (de) |
| RU (1) | RU2153885C2 (de) |
| TJ (1) | TJ294B (de) |
| WO (1) | WO1995017908A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6461851B1 (en) | 1992-11-19 | 2002-10-08 | Anticancer, Inc. | High expression modules containing two or more tandem copies of a methioninase encoding sequence |
| US5891704A (en) * | 1992-11-19 | 1999-04-06 | Anticancer, Inc. | Method to produce high levels of methioninase |
| US6911309B2 (en) * | 1993-12-29 | 2005-06-28 | The Regents Of The University Of Californnia | Nucleic acids encoding MTAse |
| US6870037B1 (en) * | 1995-07-03 | 2005-03-22 | Arch Development Corporation | Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders |
| US5861154A (en) * | 1995-10-30 | 1999-01-19 | Shionogi & Co., Ltd. | Recombinant L-methionine γ-lyase |
| JP3375834B2 (ja) | 1995-10-30 | 2003-02-10 | 塩野義製薬株式会社 | 組換えＬ−メチオニン γ−リアーゼ |
| WO2002020807A1 (fr) * | 2000-09-05 | 2002-03-14 | Shionogi & Co., Ltd. | L-methionine $g(g)-lyase a fonction modifiee |
| US20030129262A1 (en) * | 2001-08-30 | 2003-07-10 | Epner Daniel E. | Methionine restriction for cancer therapy |
| AU2003261354A1 (en) * | 2002-08-02 | 2004-02-23 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
| CA2516191A1 (en) | 2003-02-14 | 2004-09-02 | Salmedix, Inc | Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| US20110002978A1 (en) * | 2003-06-17 | 2011-01-06 | Harrison Roger G | Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
| RU2393866C2 (ru) * | 2005-03-17 | 2010-07-10 | Проекто Де Биомедисина Сима, С.Л. | Применение 5'-метилтиоаденозина (мта) для предотвращения и/или лечения аутоиммунных заболеваний и/или отторжения трансплантата |
| WO2009032057A2 (en) | 2007-08-29 | 2009-03-12 | Adam Lubin | Method for the selective therapy of disease |
| US8480731B2 (en) * | 2008-04-14 | 2013-07-09 | Medtronic ATS Medical, Inc. | Tool for implantation of replacement heart valve |
| US9987241B2 (en) | 2014-09-25 | 2018-06-05 | The Board Of Regents Of The University Of Oklahoma | Enzyme conjugate and prodrug cancer therapy |
| WO2020032951A1 (en) | 2018-08-09 | 2020-02-13 | The Board Of Regents Of The University Of Oklahoma | Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
-
1993
- 1993-12-29 US US08/176,413 patent/US5571510A/en not_active Expired - Fee Related
-
1994
- 1994-12-22 AU AU14459/95A patent/AU694161B2/en not_active Ceased
- 1994-12-22 RU RU96116159/14A patent/RU2153885C2/ru not_active IP Right Cessation
- 1994-12-22 AT AT95906124T patent/ATE221785T1/de not_active IP Right Cessation
- 1994-12-22 CZ CZ19961869A patent/CZ291281B6/cs not_active IP Right Cessation
- 1994-12-22 CA CA002180262A patent/CA2180262A1/en not_active Abandoned
- 1994-12-22 JP JP7518169A patent/JPH09507754A/ja not_active Ceased
- 1994-12-22 WO PCT/US1994/014919 patent/WO1995017908A1/en not_active Ceased
- 1994-12-22 EP EP95906124A patent/EP0805690B1/de not_active Expired - Lifetime
- 1994-12-22 TJ TJ96000320A patent/TJ294B/xx unknown
- 1994-12-22 DE DE69431167T patent/DE69431167T2/de not_active Expired - Fee Related
- 1994-12-22 HU HU9601695A patent/HU221341B1/hu not_active IP Right Cessation
- 1994-12-22 RO RO96-01324A patent/RO117542B1/ro unknown
- 1994-12-22 NZ NZ278271A patent/NZ278271A/en unknown
- 1994-12-22 CN CN94195042A patent/CN1143325A/zh active Pending
- 1994-12-22 PL PL94315229A patent/PL182298B1/pl unknown
-
1996
- 1996-06-27 NO NO962714A patent/NO962714L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69431167T2 (de) | 2003-04-17 |
| HU221341B1 (en) | 2002-09-28 |
| JPH09507754A (ja) | 1997-08-12 |
| RU2153885C2 (ru) | 2000-08-10 |
| ATE221785T1 (de) | 2002-08-15 |
| WO1995017908A1 (en) | 1995-07-06 |
| RO117542B1 (ro) | 2002-04-30 |
| EP0805690A4 (de) | 1999-05-12 |
| CZ186996A3 (en) | 1996-12-11 |
| AU1445995A (en) | 1995-07-17 |
| TJ294B (en) | 2001-03-30 |
| PL182298B1 (pl) | 2001-12-31 |
| NZ278271A (en) | 2001-07-27 |
| AU694161B2 (en) | 1998-07-16 |
| EP0805690A1 (de) | 1997-11-12 |
| CA2180262A1 (en) | 1995-07-06 |
| EP0805690B1 (de) | 2002-08-07 |
| CN1143325A (zh) | 1997-02-19 |
| CZ291281B6 (cs) | 2003-01-15 |
| HUT75070A (en) | 1997-04-28 |
| HU9601695D0 (en) | 1996-08-28 |
| US5571510A (en) | 1996-11-05 |
| NO962714D0 (no) | 1996-06-27 |
| DE69431167D1 (de) | 2002-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO962714D0 (no) | Fremgangsmåte for selektiv metionin-utsulting av maligne celler i pattedyr | |
| USD289896S (en) | Pocket telephone | |
| USD292880S (en) | Bottle | |
| USD292374S (en) | Bottle | |
| USD282031S (en) | Desk | |
| CA2085354A1 (en) | Ether lipid-nucleoside covalent conjugates | |
| IE821210L (en) | Guanine derivatives | |
| MY103388A (en) | Azithromycin and derivatives as antiprotozoal agents | |
| USD275576S (en) | Notebook insert filing folder | |
| DK1137571T3 (da) | Kollisionsmodstandsdygtig dobbeltvægget konstruktion | |
| USD283077S (en) | Racquet sports shorts | |
| USD271397S (en) | Articulated loader vehicle body | |
| USD282792S (en) | Portable desk | |
| USD298313S (en) | Electrical connector | |
| USD301687S (en) | Mine roof support plate | |
| USD292400S (en) | Headset telephone | |
| USD308763S (en) | Fashion pocket insert | |
| AU558587B2 (en) | Antiinflammatory composition of inositol and piroxicam | |
| USD292810S (en) | Doll | |
| USD298429S (en) | Telephone stand with speakerphone | |
| IT1292561B1 (it) | Snodo a pettine autocentrante alloggiato in cavita' realizzate nei lati di larghezza frontale superiore ed inferiore dei pannelli | |
| USD284659S (en) | Telephone | |
| FI860127A0 (fi) | Nya 12-amino-pyridazino/4',5':3,4/ pyrrolo/2,1-a/isokinoliner, foerfarande foer deras framstaellning och anvaendning. | |
| USD293055S (en) | Shelf for computer keyboard or the like | |
| CA2037900A1 (en) | Pokeweed antiviral protein - monoclonal antibody conjugates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |